GEHCNasdaqX-Ray Apparatus & Tubes & Related Irradiation ApparatusFiscal year ends December 31

GE HealthCare Technologies Inc.

Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Jul 29, 2026

$69.76+0.19 (+0.27%)

Close on Oct 19, 2026

Market cap: $31.67B
P/E (TTM): 16.0
Dividend yield: 0.20%

GE HealthCare Technologies Inc. income statement

Annual Quarterly TTM

Millions of USD, except per-share data. Shares in millions.

Line item	FY 2025 2025-12-31	FY 2024 2024-12-31	FY 2023 2023-12-31	FY 2022 2022-12-31	FY 2021 2021-12-31
Revenue	20,625	19,672	19,552	18,341	17,585
Gross Profit	8,248	8,205	7,922	7,179	7,174
Research & Development	1,260	1,311	1,205	1,026	816
Selling, General & Admin	4,225	4,269	4,282	3,631	3,563
Operating Expenses	5,485	5,580	5,487	4,657	4,379
Operating Income	2,763	2,625	2,435	2,522	2,795
Income from Equity Investments	3.00	8.00	11	13	27
Other Non-Operating Income	157	55	86	62	123
Merger & Restructuring Charges	102	93	54	146	155
Asset Impairment Charges	0	0	–	0	0
Gain (Loss) on Investments	112	-22	1.00	-31	3.00
Gain (Loss) on Sale of Assets	5.00	0	0	1.00	2.00
Pretax Income	2,768	2,581	2,361	2,512	2,875
Income Tax Expense	614	531	743	563	600
Income from Continuing Operations	2,084	1,993	1,572	1,898	2,229
Income from Discontinued Operations	0	0	-4.00	18	18
Net Income incl. Noncontrolling Interests	2,154	2,050	1,614	1,967	2,293
Minority Interest in Earnings	70	57	46	51	46
Net Income	2,084	1,993	1,568	1,916	2,247
Net Income to Common	2,084	1,993	1,385	1,916	2,247
EPS (Basic)(per share)	4.56	4.37	3.05	4.22	4.95
EPS (Diluted)(per share)	4.55	4.34	3.03	4.22	4.95
Shares Outstanding (Basic, Weighted)(shares)	456	456	455	454	454
Shares Outstanding (Diluted, Weighted)(shares)	458	459	458	454	454
Dividend per Share(per share)	0.14	0.13	0.12	–	–

Italic numbers are calculated by StockData (for example Q4 = full year − nine months). Per-share data and share counts are adjusted for stock splits. Hover a number for its source; click it to open the filing on SEC.gov. Click a row to chart it.

Ratios

Latest available, balances at Jun 30, 2026

Profitability, TTM

Gross margin: 39.5%
Operating margin: 12.9%
Net margin: 9.3%
Return on equity, FY2025: 22.1%

Financial strength

Current ratio: 1.26
Debt to equity: 0.92
Debt to assets: 27.1%
Cash to current liabilities: 25.0%

Valuation

P/E ratio: 16.0
Price to sales: 1.49
Price to book: 2.89
Dividend yield: 0.20%